Moreover, both the epigenetic and transcriptional levels of ITGA5 are effective in predicting TMZ and bevacizumab resistance, revealing the novel roles of ITGA5 in predicting the treatment outcomes of glioma [49]. The gene discussed is ITGA5; the disease is glioma.